[pharmaco midterms] cardiovascular

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/73

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

74 Terms

1
New cards

Hypertension (HTN) Definition

Sustained, reproducible increase in BP: systolic >140 mmHg or diastolic >90 mmHg. Goal: <120/80 mmHg.

2
New cards

HTN Complications

Stroke, heart failure, renal disease, and blindness.

3
New cards

BP Formula

BP = Cardiac Output (CO) × Vascular Resistance (R). CO = HR × Stroke Volume.

4
New cards

RAAS Function

Regulates blood volume, electrolyte balance, and systemic vascular resistance.

5
New cards

Beta-Blockers (-olol)

Decrease HR and contractility, lower CO, reduce sympathetic tone and renin release.

6
New cards

Beta-Blocker Adverse Effects

Bronchoconstriction (nonselective), bradycardia, orthostatic hypotension, fatigue, depression.

7
New cards

Alpha Blockers (-zosin)

Block alpha-1 receptors, reduce vascular resistance, used in HTN and BPH.

8
New cards

Prazosin Effect

Causes vasodilation in arteries and veins.

9
New cards

Alpha Blocker Adverse Effects

Reflex tachycardia, orthostatic hypotension.

10
New cards

Presynaptic Adrenergic Inhibitors

Inhibit NE release (e.g., Reserpine, Guanadrel), reduce sympathetic tone.

11
New cards

Central Acting Agents

Alpha-2 or imidazoline agonists (e.g., clonidine, methyldopa), reduce sympathetic outflow.

12
New cards

Central Acting Agent Side Effects

Dry mouth, dizziness, sedation.

13
New cards

Vasodilators

Directly relax vascular smooth muscle via second messengers like cGMP.

14
New cards

Hydralazine Use

Emergency HTN and preeclampsia.

15
New cards

Minoxidil

Vasodilator used off-label for hair growth.

16
New cards

Nitric Oxide

Endogenous vasodilator for pulmonary hypertension.

17
New cards

Vasodilator Adverse Effects

Reflex tachycardia, orthostatic hypotension, headache, nausea.

18
New cards

Thiazide Diuretics

Inhibit Na⁺ reabsorption in early distal tubule; superior for preventing cardiac events.

19
New cards

Loop Diuretics

Inhibit Na⁺/Cl⁻ reabsorption in loop of Henle (e.g., Furosemide).

20
New cards

K⁺-Sparing Diuretics

Prevent K⁺ loss (e.g., Spironolactone).

21
New cards

Diuretic Adverse Effects

Hypokalemia, orthostatic hypotension, weakness, confusion, mood changes.

22
New cards

ACE Inhibitors (-pril)

Inhibit Angiotensin I → II conversion, decrease BP, prevent vascular remodeling.

23
New cards

ARBs (-sartan)

Block angiotensin II receptors, lower BP without dry cough.

24
New cards

ACE Inhibitor Side Effects

Dry cough, angioedema, renal problems, dizziness, chest pain.

25
New cards

Calcium Channel Blockers (-dipine)

Inhibit calcium influx, promote vasodilation, lower resistance.

26
New cards

Dihydropyridines

Act on vascular smooth muscle (e.g., Nifedipine).

27
New cards

Non-Dihydropyridines

Act on myocardial cells to reduce HR and contractility.

28
New cards

CCB Adverse Effects

Reflex tachycardia, MI risk, pedal edema, arrhythmias.

29
New cards

Ganglionic Blockers

Nicotinic cholinergic antagonists that block sympathetic and parasympathetic transmission.

30
New cards

Ganglionic Blocker Side Effects

GI distress, urinary retention, visual disturbances.

31
New cards

Rehab Concerns with Antihypertensives

Monitor orthostatic hypotension; avoid systemic heat; beta-blockers blunt HR response.

32
New cards

Arrhythmia Definition

Any abnormal cardiac rhythm including bradycardia, tachycardia, or irregular rhythm.

33
New cards

Class I Antiarrhythmics

Sodium channel blockers; proarrhythmic risk, especially in HF and MI.

34
New cards

Class I Side Effects

Dizziness, visual disturbance, GI problems.

35
New cards

Class II Antiarrhythmics

Beta-blockers reduce sympathetic activity, HR, AV node conduction.

36
New cards

Class II Side Effects

Bradycardia, bronchoconstriction.

37
New cards

Class III Antiarrhythmics

Potassium channel blockers; prolong repolarization; treat VT and VF.

38
New cards

Amiodarone

Class III agent with effects of all four classes; risk of pulmonary, thyroid, liver toxicity.

39
New cards

Class IV Antiarrhythmics

Calcium channel blockers; affect SA/AV node, treat SVT and AF.

40
New cards

Class IV Side Effects

Bradycardia, dizziness, headache.

41
New cards

Non-Pharmacologic Arrhythmia Tx

Includes pacemakers, defibrillators, ablation.

42
New cards

Angina Pathophysiology

Caused by mismatch between O₂ supply and demand → ischemia.

43
New cards

Organic Nitrates

Converted to nitric oxide, cause vasodilation, reduce preload/afterload.

44
New cards

Nitroglycerin

Common nitrate for angina, various administration routes.

45
New cards

Nitrate Side Effects

Headache, dizziness, orthostatic hypotension.

46
New cards

Heart Failure Causes

Myocardial damage, workload, and neurohumoral compensation.

47
New cards

Inotropic Drugs

Increase cardiac contractility (e.g., Digoxin, Dobutamine, Milrinone).

48
New cards

Digoxin

Secondary agent in HF; narrow therapeutic index.

49
New cards

Anticoagulants

Prevent venous clots; treat DVT, embolism; used in Afib and post-surgery.

50
New cards

Heparin

IV anticoagulant enhancing antithrombin; immediate effect.

51
New cards

LMWHs

Subcutaneous anticoagulants targeting Factor Xa; safer, no monitoring needed.

52
New cards

Warfarin

Oral anticoagulant; inhibits vitamin K-dependent factors; monitored by PT/INR.

53
New cards

Direct Thrombin Inhibitors

Block thrombin activity (e.g., Dabigatran); reduce stroke risk in Afib.

54
New cards

Factor Xa Inhibitors

Inhibit Factor Xa (e.g., Apixaban, Rivaroxaban); oral use for cardiac patients.

55
New cards

Anticoagulant Side Effects

Hemorrhage, thrombocytopenia, GI distress.

56
New cards

Aspirin (ASA)

Irreversibly inhibits COX → ↓ TXA2; prevents arterial thrombosis.

57
New cards

ADP Receptor Blockers

Block platelet activation signal; prevent MI, stroke post-stent.

58
New cards

GPIIb/IIIa Inhibitors

Block platelet fibrinogen receptor; strong platelet inhibition during PCI.

59
New cards

Other Antiplatelets

Dipyridamole, Cilostazol, Pentoxifylline; used in stroke or PAD.

60
New cards

Fibrinolytics

Dissolve clots via plasmin activation; used for MI, stroke, PE.

61
New cards

Streptokinase/Urokinase

Activate plasminogen; used IV in emergencies.

62
New cards

tPA (Alteplase)

Recombinant fibrinolytic used for stroke and MI.

63
New cards

Fibrinolytic Side Effects

Hemorrhage, GI bleeding, bruising, allergic reactions.

64
New cards

Antifibrinolytics

Prevent excessive clot breakdown (e.g., Tranexamic acid, Amicar).

65
New cards

Antifibrinolytic Side Effects

Nausea, dizziness, headache.

66
New cards

Dyslipidemia

Elevated lipids in blood → atherosclerosis, clot risk.

67
New cards

Statins

Inhibit HMG-CoA reductase → ↓ LDL, TG; ↑ HDL; CV risk ↓ by 50%.

68
New cards

Statin Side Effects

Myopathy, rhabdomyolysis, peripheral neuropathy.

69
New cards

Fibric Acids

Activate PPAR-α; ↓ TGs, ↑ HDL; used in diabetes-related dyslipidemia.

70
New cards

Fibric Acid Side Effects

Myopathy, especially with statins.

71
New cards

Bile Acid Binders

Bind GI bile acids → ↓ cholesterol; may improve glucose in diabetes.

72
New cards

Niacin

↓ LDL/TG, ↑ HDL; safe with statins; causes flushing.

73
New cards

Ezetimibe

Inhibits cholesterol absorption; ↓ LDL; combined with statins.

74
New cards

Dyslipidemia Rehab Concerns

Promote exercise/diet; watch for statin-induced myopathy.